Back to Agenda
Session 5: Real World Evidence Studies in Peer Reviewed Literature: Moving Towards a Better Approach
Session Chair(s)
Sarah Martin, PHD, MS
Senior Director - Global Regulatory Policy (Americas), Eli Lilly and Company, United States
Whitney Steele
Health Scientist, FDA, United States
Poor-quality RWE studies are increasingly published due to easy access to large datasets and low barriers to analysis, creating challenges for journal editors and peer reviewers. This session will explore how researchers, publishers, and reviewers can improve the reliability and transparency of RWE studies in literature. Panelists will share stakeholder perspectives and discuss opportunities to strengthen practices across the RWE research lifecycle.
Learning Objective : - Recognize key indicators of high-quality RWE studies and studies and evaluate study methods and reporting with greater confidence
- Outline steps the research community can take to support high-quality peer review of real-world evidence studies
Speaker(s)
Jeffrey Brown, PHD
Chief Scientific Officer, TriNetX, United States
Real World Evidence Studies in Peer Reviewed Literature: Moving Towards a Better Approach
Shirley Wang, PHD, MSC, FISPE
Associate Professor of Medicine, Harvard Medical School, United States
Speaker
Jaclyn Bosco, MPH, FISPE
Vice President & General Manager, Global Head of Epidemiology & Scientific Strat, IQVIA, United States
Speaker
Have an account?